InvestorsHub Logo
Followers 0
Posts 525
Boards Moderated 0
Alias Born 05/06/2013

Re: None

Wednesday, 09/18/2013 1:55:57 PM

Wednesday, September 18, 2013 1:55:57 PM

Post# of 403046
Harvard is objectively testing Kevetrin. Management should not have any influence on this trial. The company receive updates and DF might request information from CTIX but they cannot not have any influence on the trial after it has begun.

Its really the whole point of it all and really why it so important that Dana Farber is running the trial -creditability cannot be questioned here on outcomes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News